Skip to content

HyCON Labs

+1 (631) 210-5235

info@hyconlabs.com

  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
hyconlabs-final-logo-3 (1) (1)
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
Contact Us
Home » Oral Technology

Oral Technology

Menu
  • Services
    • Product Development
      • Formulation
        • Preformulation Studies
        • Formulation Development
      • Analytical
        • Analytical Method Development
        • Analytical Testing
        • Stability Testing
      • Polymorph Screening
      • IND Enabling Studies
      • GLP Toxicology Studies
      • Therapeutic Area
        • Orphan Disease / Rare Disease
        • Oncology
        • CNS / Neurology
        • Cardiometabolic Diseases
      • Pediatrics
    • Processing Technologies
      • Spray Drying
      • Wurster Fluid Bed Coating
      • Hot Melt Extrusion
      • Micronization & Milling
      • Particle Engineering
    • Clinical Trial Supply
      • Clinical Manufacturing
      • Solutions by Phase
        • Preclinical Manufacturing
        • Phase 1 Clinical Manufacturing
        • Phase 2 Clinical Manufacturing
        • Phase 3 Clinical Manufacturing
      • Comparator Sourcing
      • Direct-to-Patient Services
      • Clinical Returns
      • Clinical Packaging
      • Project & Supply Management
    • Pharmaceutical Manufacturing
      • Commercial Manufacturing
      • over-the-counter-contract-manufacturing
      • Technology Transfers
      • High Potent API (HPAPI)
      • Scheduled Substances
      • Packaging
      • Regulatory Services
  • Dosage Forms
    • Oral Dosage
      • Oral Solid Dosage
      • Tablets
      • Capsules
      • Softgel
      • Oral Films
      • Oral Suspension & Solutions
      • Semi-Solids
      • Powders & Granules
    • Injectables / Parenterals
    • Topical
      • Semi Solids Dosage Forms
      • Transdermal Patches
      • Ophthalmic / Ocular
    • Transdermal
      • Semi Solids Dosage Forms
      • Transdermal Patches
    • Ophthalmic / Ocular
    • Inhalables / Nasal
    • Liquids
  • Formulation Technologies
    • Bioavailability Enhancement
    • Lipid Nanoparticles
      • Nanostructured Lipid Carriers
      • Liposomes
      • Solid Lipid Nanoparticles
      • Self-Emulsifying Drug Delivery Systems
      • Nanoemulsions
    • Lipid-Based Drug Delivery
    • Nanoparticles
      • Polymeric Nanoparticles
      • Nanocrystals
    • Amorphous Solid Dispersions
    • Controlled Release
    • Sustained Release
    • Microencapsulation
    • Multiparticulate
    • Taste Masking
    • Orally Disintegrating Tablets
    • Abuse Deterrent
  • Resources
    • Articles
    • Case Study
    • E-Book
    • Executive Summary
    • Offering Sheet
    • White Paper
  • About
    • Schedule a Meeting
    • Corporate Responsibility
    • Contact Us
  • Two scientist experimenting in a pharma lab
    Development & Bioavailability | Manufacturing | Oral Technology

    Enteric-Protected Solid Oral Dosage Form Development 

    Development & Bioavailability, Manufacturing, Oral Technology

    Download Full Case Study Abstract: This comprehensive case study offers an exhaustive examination into the precise development of an enteric-protected solid oral…

    Read More Enteric-Protected Solid Oral Dosage Form Development Continue

  • Image showing scientist performing chemical experiment
    Development & Bioavailability | Manufacturing | Oral Technology

    Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug

    Development & Bioavailability, Manufacturing, Oral Technology

    Abstract: This case study provides a deep dive into Hycon’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…

    Read More Development of a Multi-API (Multiparticulate) Fixed-Dose Combination DrugContinue

  • Image showing a scientific experiment
    Oral Technology

    Formulation Technologies for Small Molecule Drugs

    Oral Technology

    INTRODUCTION The development of new chemical entities (NCEs) has shifted in recent years toward smaller drug developers, creating a more varied market…

    Read More Formulation Technologies for Small Molecule DrugsContinue

  • Image showing Tablet dissolving in water
    Development & Bioavailability | Dosage Form Design | Oral Technology

    How to Select an Optimal Formulation Strategy for Solubility

    Development & Bioavailability, Dosage Form Design, Oral Technology

    Why has solubility become a challenging aspect? The effectiveness of orally administered medicines hinges on the drug’s ability to dissolve in the gastrointestinal tract and promptly…

    Read More How to Select an Optimal Formulation Strategy for SolubilityContinue

  • Image showing a Lady showing a pill
    Development & Bioavailability | Oral Technology | Softgel Technology

    Softgel Technology’s Versatility: Encapsulating a Volatile Compound:

    Development & Bioavailability, Oral Technology, Softgel Technology

    Download

    Read More Softgel Technology’s Versatility: Encapsulating a Volatile Compound:Continue

  • Image showing stethoscope and medicines
    Development & Bioavailability | Dosage Form Design | Oral Technology

    How to Accelerate Your Drug Product Development

    Development & Bioavailability, Dosage Form Design, Oral Technology

    DRUG DEVELOPMENT AND FORMULATION IS SCIENCE. DOSE DESIGN TO CREATE SUCCESSFUL TREATMENTS IS ART. Developing successful treatments that meet the needs of…

    Read More How to Accelerate Your Drug Product DevelopmentContinue

Image of ISO Certified Organization
Logo of Current Good Manufacturing Practice
Made in USA Logo
Seal of the United States Drug Enforcement Administration
FDA Approved Icon
WHO - GMP Logo
Certified Organization Logo

Contact us today to start your project in 1 week!

Call +1 (631) 210-5235 to hit the ground running

Contact Us
HyCON Labs a premier small molecule CDMO, enabling pharmaceutical partners to slash development, and manufacturing costs and bring speed to market.
Youtube Linkedin
Services
  • Product Development
  • Processing Technologies
  • Clinical Trial Supply
  • Drug Product Manufacturing
  • Solutions by Phase
Explore
  • Dosage Forms
  • Formulation Technologies
  • Resources
  • About Us
  • Our Locations
Get In Touch

Phone No.: +1 631-210-5235

E-Mail ID: info@hyconlabs.com

© 2025 HyCON Labs Solutions. All Rights Reserved.